Categories
Launching of ASEAN IP Portal-Background History
The protection of Intellectual Property (IP) rights have become a concern to the Government and the creative people. The IP rights deal with most common issues like public health, education, trade, industrial policy, traditional knowledge, biodiversity, biotechnology, the internet, the cultural industries or climate change. It has become difficult to track the IP infringement due […]
Read more
Dismissal of Bayer Appeal against Natco on cancer drug
A compulsory license is a legal instrument by which a Government allows someone else to manufacture and sell the product that has been patented by another company. Bangalore based generic company was the first ever company that have the compulsory license for manufacturing and marketing the patented drug Nexavar. In the year 2008, Bayer obtained […]
Read more
Patentability-First step of monetization of new invention
An invention requires a huge amount of money as well as dedicated effort. If you do not turn your unique idea into a positive outcome, your effort will be meaningless. Your dream will be successful by only patenting your idea. It is wise to hire a patent attorney for submission of patent application. The main […]
Read more
Controversy on Compulsory License Act in India
A compulsory license is a legal instrument by which a government can force the patent owner to license out their patent product to others. Compulsory licensing is a common practice in many countries. The practice is generally used in the field of pharmaceutical industries, technology, music and the performing Arts. It is a unique example […]
Read more
An analysis of the patient assistance program launched by the big pharmaceutical companies of India
The latest decisions of the “Intellectual Property Appellate Board’s (IPAB)”to revoke the patent protection of Gefitinib, the cancer drug patented by AstraZeneca; Pegasys, hepatitis drug patented by Roche and Nexavar, the cancer drug patented by Bayer are the major setbacks of big pharmaceutical companies of India. In the above cases, the Indian generic companies have […]
Read more
American invents act has stopped the damage charge claiming false marking statute.
The American invents act has taken a major legal step against the marking statute. Before the enforcement of American invents act, anyone could file a case against any company accusing for selling the product that marked with numbers of expired patents or patents which did not cover the products. The suit was filed as qui […]
Read more
16192 Coastal Highway, Lewes, Delaware 19958, USA